These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation. Sitruk-Ware R. Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138 [Abstract] [Full Text] [Related]
4. Routes of delivery for progesterone and progestins. Sitruk-Ware R. Maturitas; 2007 May 20; 57(1):77-80. PubMed ID: 17368973 [Abstract] [Full Text] [Related]
7. Exogenous progestagens and the human breast. Sitruk-Ware R, Plu-Bureau G. Maturitas; 2004 Sep 24; 49(1):58-66. PubMed ID: 15351097 [Abstract] [Full Text] [Related]
8. Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies. Burkman RT. Am J Manag Care; 2001 Nov 24; 7(18 Suppl):S571-4. PubMed ID: 11727395 [Abstract] [Full Text] [Related]
9. Pharmacology of estrogens and progestogens: influence of different routes of administration. Kuhl H. Climacteric; 2005 Aug 24; 8 Suppl 1():3-63. PubMed ID: 16112947 [Abstract] [Full Text] [Related]
11. Progestogens and brain: an update. Pluchino N, Cubeddu A, Giannini A, Merlini S, Cela V, Angioni S, Genazzani AR. Maturitas; 2009 Apr 20; 62(4):349-55. PubMed ID: 19167174 [Abstract] [Full Text] [Related]
12. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G. J Cardiovasc Med (Hagerstown); 2009 Jan 20; 10(1):85-92. PubMed ID: 19145119 [Abstract] [Full Text] [Related]